(Washington, D.C., March 4, 2021) – Global Liver Institute (GLI) is pleased to announce that the 2021 International NASH Day (#NASHday) will be held on June 10, 2021, with the...
As more Americans have received at least one dose of a COVID-19 vaccine than have tested positive for the virus1, we are seeing some hope for defeating the pandemic with science. While different...
(Washington, D.C., February 18, 2021) Today, Global Liver Institute (GLI) submitted a letter directly to U.S. Department of Health and Human Services (HHS) Secretary-Designee Xavier...
GLI’s Response to FDA Briefing on NASH Drug Development The Food and Drug Administration (FDA) held an informative briefing at the end of January titled “Regulatory Perspectives for Development of...
POLICY PERSPECTIVE The 2020 election not only resulted in a new president and vice president, but also 66 new Members of Congress. The 117th Congress will have 57 new U.S. Representatives from 28...
(Washington, D.C., February 1, 2021) – Global Liver Institute (GLI), in their mission to improve the lives of individuals and families impacted by liver disease, has announced February 2021 as...
(Washington, D.C., January 29, 2021) Thank you to the Food and Drug Administration (FDA) for the informative briefing earlier today titled, “Regulatory Perspectives for Development of Drugs for...
(Washington, D.C., January 25, 2021) On January 21, DC Health announced the plan to open up vaccine access, possibly as soon as February, to an expansive population including habitual smokers...
(Washington, D.C., January 14, 2021) In 2020, Global Liver Institute (GLI), whose mission is to improve the lives of individuals and families impacted by liver disease through promoting...
Global Liver Institute Releases U.S. NASH Action Plan 2021 is already proving itself to be a year of action. While the world adjusted, innovated and rose to the challenge of fighting a global...
Recent News
As Deadly Liver Cancer Rises, Collaborative, Targeted Prevention and Surveillance Necessary Global Liver Institute’s #OctoberIs4Livers Campaign Sheds Light on Unique Challenges and Solutions in Communities Facing Barriers(Washington, D.C., October 1, 2024) – Global...
Congress reconvenes in September for its last push to legislate before the November elections Congress is entering a very busy work period in September, the last before the November elections. GLI is preparing for its Advanced Advocacy Academy (A3) and subsequent day...
Millennials and Generation X Face Higher Risk of Liver Cancer Than Previous Generations Thank you for being a part of Liver Cancer News! As we gear up for Liver Cancer Awareness Month next month, we are thrilled to announce the launch of a comprehensive patient...
Let’s Ensure Access to Treatment for PBC Patients - Pediatric & Rare Liver Diseases NewsAmplifying the rare liver disease voice for PBC patients during our monthly policy call Global Liver Institute’s August Pediatric and Rare Liver Diseases monthly...
Understanding the New EASL-EASD-EASO Guidelines on MASLD New Clinical Practice Guidelines for MASLD, developed jointly by EASL, EASD, and EASO, update the 2016 guidelines to reflect recent advancements. They focus on early identification and intervention and the...
